189 related articles for article (PubMed ID: 27329594)
1. Overexpression of TELO2 decreases survival in human high-grade gliomas.
Feng SW; Chen Y; Tsai WC; Chiou HC; Wu ST; Huang LC; Lin C; Hsieh CC; Yang YJ; Hueng DY
Oncotarget; 2016 Jul; 7(29):46056-46066. PubMed ID: 27329594
[TBL] [Abstract][Full Text] [Related]
2. DDX3X Biomarker Correlates with Poor Survival in Human Gliomas.
Hueng DY; Tsai WC; Chiou HY; Feng SW; Lin C; Li YF; Huang LC; Lin MH
Int J Mol Sci; 2015 Jul; 16(7):15578-91. PubMed ID: 26184164
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of NIMA-related kinase 2 is associated with poor prognoses in malignant glioma.
Liu H; Liu B; Hou X; Pang B; Guo P; Jiang W; Ding Q; Zhang R; Xin T; Guo H; Xu S; Pang Q
J Neurooncol; 2017 May; 132(3):409-417. PubMed ID: 28321704
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of microRNA-15b correlates with unfavorable prognosis and malignant progression of human glioma.
Pang C; Guan Y; Zhao K; Chen L; Bao Y; Cui R; Li G; Wang Y
Int J Clin Exp Pathol; 2015; 8(5):4943-52. PubMed ID: 26191187
[TBL] [Abstract][Full Text] [Related]
5. Up-Regulation of Long Non-Coding RNA AB073614 Predicts a Poor Prognosis in Patients with Glioma.
Hu L; Lv QL; Chen SH; Sun B; Qu Q; Cheng L; Guo Y; Zhou HH; Fan L
Int J Environ Res Public Health; 2016 Apr; 13(4):433. PubMed ID: 27104549
[TBL] [Abstract][Full Text] [Related]
6. Slit2 and Robo1 expression as biomarkers for assessing prognosis in brain glioma patients.
Liu L; Li W; Geng S; Fang Y; Sun Z; Hu H; Liang Z; Yan Z
Surg Oncol; 2016 Dec; 25(4):405-410. PubMed ID: 27916173
[TBL] [Abstract][Full Text] [Related]
7. Epithelial cell transformation sequence 2 is a potential biomarker of unfavorable survival in human gliomas.
Cheng YS; Lin C; Cheng YP; Yu YL; Tang CT; Hueng DY
Neurol India; 2014; 62(4):406-9. PubMed ID: 25237947
[TBL] [Abstract][Full Text] [Related]
8. PinX1 is up-regulated and associated with poor patients' survival in gliomas.
Bai J; Chen YS; Mei PJ; Liu QH; Du Y; Zheng JN
Int J Clin Exp Pathol; 2015; 8(6):6952-9. PubMed ID: 26261583
[TBL] [Abstract][Full Text] [Related]
9. High level of Sema3C is associated with glioma malignancy.
Vaitkienė P; Skiriutė D; Steponaitis G; Skauminas K; Tamašauskas A; Kazlauskas A
Diagn Pathol; 2015 Jun; 10():58. PubMed ID: 26032848
[TBL] [Abstract][Full Text] [Related]
10. Nrf2 Expressions Correlate with WHO Grades in Gliomas and Meningiomas.
Tsai WC; Hueng DY; Lin CR; Yang TC; Gao HW
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27187376
[TBL] [Abstract][Full Text] [Related]
11. Stratifin expression is a novel prognostic factor in human gliomas.
Deng J; Gao G; Wang L; Wang T; Yu J; Zhao Z
Pathol Res Pract; 2011 Nov; 207(11):674-9. PubMed ID: 21940111
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of phosphatidylethanolamine-binding protein 4 (PEBP4) strongly associates with human gliomas grade.
Huang RQ; Shi DL; Huang W; Chen F; Lu YC
J Neurooncol; 2016 Apr; 127(2):235-42. PubMed ID: 26725095
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of ubiquitin-specific protease 2a (USP2a) and nuclear factor erythroid 2-related factor 2 (Nrf2) in human gliomas.
Boustani MR; Khoshnood RJ; Nikpasand F; Taleshi Z; Ahmadi K; Yahaghi E; Goudarzi PK
J Neurol Sci; 2016 Apr; 363():249-52. PubMed ID: 27000259
[TBL] [Abstract][Full Text] [Related]
14. Somatic CPEB4 and CPEB1 genes mutations spectrum on the prognostic predictive accuracy in patients with high-grade glioma and their clinical significance.
Boustani MR; Mehrabi F; Yahaghi E; Khoshnood RJ; Shahmohammadi M; Darian EK; Goudarzi PK
J Neurol Sci; 2016 Apr; 363():80-3. PubMed ID: 27000226
[TBL] [Abstract][Full Text] [Related]
15. High CHI3L1 expression is associated with glioma patient survival.
Steponaitis G; Skiriutė D; Kazlauskas A; Golubickaitė I; Stakaitis R; Tamašauskas A; Vaitkienė P
Diagn Pathol; 2016 Apr; 11():42. PubMed ID: 27121858
[TBL] [Abstract][Full Text] [Related]
16. The Application of FOXO1A Expression Predicts Aggressive Behavior and Poor Prognosis in Gliomas.
Huang ZY; Hueng DY; Tsai WC
Appl Immunohistochem Mol Morphol; 2020 Jan; 28(1):74-82. PubMed ID: 30664534
[TBL] [Abstract][Full Text] [Related]
17. ARID4B is a good biomarker to predict tumour behaviour and decide WHO grades in gliomas and meningiomas.
Tsai WC; Hueng DY; Nieh S; Gao HW
J Clin Pathol; 2017 Feb; 70(2):162-167. PubMed ID: 27451434
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of chromatin remodeling factor CHD5 is associated with a poor prognosis in human glioma.
Wang L; He S; Tu Y; Ji P; Zong J; Zhang J; Feng F; Zhao J; Gao G; Zhang Y
J Clin Neurosci; 2013 Jul; 20(7):958-63. PubMed ID: 23707602
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of Cell-Surface Marker SLC16A1 Shortened Survival in Human High-Grade Gliomas.
Lin HH; Tsai WC; Tsai CK; Chen SH; Huang LC; Hueng DY; Hung KC
J Mol Neurosci; 2021 Aug; 71(8):1614-1621. PubMed ID: 33641091
[TBL] [Abstract][Full Text] [Related]
20. RIZ1: a potential tumor suppressor in glioma.
Zhang C; Zhu Q; He H; Jiang L; Qiang Q; Hu L; Hu G; Jiang Y; Ding X; Lu Y
BMC Cancer; 2015 Dec; 15():990. PubMed ID: 26690953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
